144 related articles for article (PubMed ID: 31496327)
41. Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.
Cowan ML; Springer S; Nguyen D; Taheri D; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; Del Carmen Rodriguez Pena M; VandenBussche CJ; Olson MT; Cunha I; Fujita K; Ertoy D; Kinzler K; Bivalacqua T; Papadopoulos N; Vogelstein B; Netto GJ
Hum Pathol; 2016 Jul; 53():8-13. PubMed ID: 26980028
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
[TBL] [Abstract][Full Text] [Related]
43. Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma.
Weyerer V; Weisser R; Moskalev EA; Haller F; Stoehr R; Eckstein M; Zinnall U; Gaisa NT; Compérat E; Perren A; Keck B; Allory Y; Kristiansen G; Wullich B; Agaimy A; Hartmann A; Bertz S
Histopathology; 2019 Dec; 75(6):865-875. PubMed ID: 31348552
[TBL] [Abstract][Full Text] [Related]
44. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
45. Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.
Almassi N; Whiting K; Toubaji A; Lenis AT; Jordan EJ; Won H; Regazzi AM; Chen YB; Gopalan A; Sirintrapun SJ; Fine SW; Tickoo SK; Ostrovnaya I; Pietzak EJ; Cha EK; Goh AC; Donahue TF; Herr HW; Donat SM; Dalbagni G; Bochner BH; Teo MY; Funt SA; Rosenberg JE; Reuter VE; Bajorin DF; Solit DB; Al-Ahmadie H; Iyer G
JCO Precis Oncol; 2022 Jun; 6():e2100392. PubMed ID: 35731998
[TBL] [Abstract][Full Text] [Related]
46. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
Thiem S; Herold T; Krafft U; Bremmer F; Tolkach Y; Szász AM; Kriegsmann J; Gaisa NT; Niedworok C; Szarvas T; Reis H
Pathol Int; 2017 Dec; 67(12):597-601. PubMed ID: 29047227
[TBL] [Abstract][Full Text] [Related]
47. Rapid clinical mutational testing of
Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
[TBL] [Abstract][Full Text] [Related]
48. Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report.
Shelekhova KV; Zhuravlev AS; Krylova DD; Konstantinov AS; Shtan LV; Kheinshtein VA
Int J Surg Pathol; 2017 Sep; 25(6):563-566. PubMed ID: 28449606
[TBL] [Abstract][Full Text] [Related]
49. Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma.
Reis H; Niedworok C; Szarvas T
Pathology; 2017 Aug; 49(5):561-562. PubMed ID: 28666639
[No Abstract] [Full Text] [Related]
50. Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
[TBL] [Abstract][Full Text] [Related]
51. Identification of molecular targets in vulvar cancers.
Palisoul ML; Mullen MM; Feldman R; Thaker PH
Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
[TBL] [Abstract][Full Text] [Related]
52. KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas.
Alexander RE; Lopez-Beltran A; Montironi R; MacLennan GT; Post KM; Bilbo SA; Jones TD; Huang W; Rao Q; Sen JD; Meehan K; Cornwell A; Miravalle L; Cheng L
Histopathology; 2012 Dec; 61(6):1036-42. PubMed ID: 22804747
[TBL] [Abstract][Full Text] [Related]
53. Current Understanding of Urachal Adenocarcinoma and Management Strategy.
Claps M; Stellato M; Zattarin E; Mennitto A; Sepe P; Guadalupi V; Mennitto R; de Braud FGM; Verzoni E; Procopio G
Curr Oncol Rep; 2020 Jan; 22(1):9. PubMed ID: 31989430
[TBL] [Abstract][Full Text] [Related]
54. Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma.
Hang JF; Pan CC
Pathology; 2017 Apr; 49(3):316-317. PubMed ID: 28285720
[No Abstract] [Full Text] [Related]
55. Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas.
Harthimmer MR; Stolborg U; Pfeiffer P; Mortensen MB; Fristrup C; Detlefsen S
J Clin Pathol; 2019 Nov; 72(11):762-770. PubMed ID: 31256008
[TBL] [Abstract][Full Text] [Related]
56. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
[TBL] [Abstract][Full Text] [Related]
57. Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma: author reply.
Hang JF; Pan CC
Pathology; 2017 Aug; 49(5):562-563. PubMed ID: 28666644
[No Abstract] [Full Text] [Related]
58. Next-generation sequencing for molecular diagnosis of lung adenocarcinoma specimens obtained by fine needle aspiration cytology.
Qiu T; Guo H; Zhao H; Wang L; Zhang Z
Sci Rep; 2015 Jun; 5():11317. PubMed ID: 26066407
[TBL] [Abstract][Full Text] [Related]
59. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
[TBL] [Abstract][Full Text] [Related]
60. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
Youssef O; Sarhadi V; Ehsan H; Böhling T; Carpelan-Holmström M; Koskensalo S; Puolakkainen P; Kokkola A; Knuutila S
World J Gastroenterol; 2017 Dec; 23(47):8291-8299. PubMed ID: 29307989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
